Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Pasta

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2012
Risk factors for rate of decline in FEV1 in adults with cystic fibrosisMichael W Konstan, Jeffrey S Wagener, Donald R Vandevanter, et al.
Pediatric Pulmonology|August 19, 2010
Trends in the use of routine therapies in cystic fibrosis: 1995-2005Michael W Konstan, Donald R VanDevanter, Lawrence Rasouliyan, et al.
Urology|June 9, 2004
Obstructive lower urinary tract symptoms correlate with erectile dysfunctionSean P Elliott, Mittul Gulati, David J Pasta, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSUREJoycelyn L Speight, Eric P Elkin, David J Pasta, et al.
Pediatric Pulmonology|October 11, 2008
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosisGregory S Sawicki, Lawrence Rasouliyan, David J Pasta, et al.
Pediatric Pulmonology|June 19, 2015
Decline in lung function does not predict future decline in lung function in cystic fibrosis patientsMargaret Rosenfeld, Donald R VanDevanter, Clement L Ren, et al.
Pediatric Pulmonology|August 14, 2012
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosisJeffrey S Wagener, Lawrence Rasouliyan, Donald R VanDevanter, et al.
Pediatric Pulmonology|August 19, 2010
Pulmonary outcome prediction (POP) tools for cystic fibrosis patientsDonald R VanDevanter, Jeffrey S Wagener, David J Pasta, et al.
Pediatric Pulmonology|September 18, 2010
Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosisGregory S Sawicki, Lawrence Rasouliyan, Ann H McMullen, et al.
American Journal of Respiratory and Critical Care Medicine|June 16, 2017
Patients with Cystic Fibrosis and a G551D or Homozygous F508del Mutation: Similar Lung Function DeclineGregory S Sawicki, Edward F McKone, Stefanie J Millar, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2012
Risk factors for rate of decline in FEV1 in adults with cystic fibrosisMichael W Konstan, Jeffrey S Wagener, Donald R Vandevanter, et al.
Pediatric Pulmonology|August 19, 2010
Trends in the use of routine therapies in cystic fibrosis: 1995-2005Michael W Konstan, Donald R VanDevanter, Lawrence Rasouliyan, et al.
Urology|June 9, 2004
Obstructive lower urinary tract symptoms correlate with erectile dysfunctionSean P Elliott, Mittul Gulati, David J Pasta, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSUREJoycelyn L Speight, Eric P Elkin, David J Pasta, et al.
Pediatric Pulmonology|October 11, 2008
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosisGregory S Sawicki, Lawrence Rasouliyan, David J Pasta, et al.
Pediatric Pulmonology|June 19, 2015
Decline in lung function does not predict future decline in lung function in cystic fibrosis patientsMargaret Rosenfeld, Donald R VanDevanter, Clement L Ren, et al.
Pediatric Pulmonology|August 14, 2012
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosisJeffrey S Wagener, Lawrence Rasouliyan, Donald R VanDevanter, et al.
Pediatric Pulmonology|August 19, 2010
Pulmonary outcome prediction (POP) tools for cystic fibrosis patientsDonald R VanDevanter, Jeffrey S Wagener, David J Pasta, et al.
Pediatric Pulmonology|September 18, 2010
Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosisGregory S Sawicki, Lawrence Rasouliyan, Ann H McMullen, et al.
American Journal of Respiratory and Critical Care Medicine|June 16, 2017
Patients with Cystic Fibrosis and a G551D or Homozygous F508del Mutation: Similar Lung Function DeclineGregory S Sawicki, Edward F McKone, Stefanie J Millar, et al.
Pageof 10